7 results on '"Sizemore, Lindsey"'
Search Results
2. Birth Outcomes Among People with Hepatitis C in Pregnancy — Three U.S. States, 2018–2021.
- Author
-
Woodworth, Kate R., Newton, Suzanne M., Tannis, Ayzsa, Reynolds, Megan R., Olsen, Emily O., Sizemore, Lindsey, Wingate, Heather, Orkis, Lauren, Reynolds, Bethany, Longcore, Nicole, Thomas, Nadia, Kim, Shin Y., Panagiotakopoulos, Lakshmi, Wester, Carolyn, Delman, Dana Meaney, Gilboa, Suzanne M., and Tong, Van T.
- Subjects
HEPATITIS C diagnosis ,SUBSTANCE abuse ,PUBLIC health surveillance ,SMALL for gestational age ,NEONATAL abstinence syndrome ,RESEARCH funding ,PREMATURE infants ,PREGNANCY outcomes ,PREGNANT women ,ATTITUDES of mothers ,NEONATAL intensive care ,DESCRIPTIVE statistics ,PREGNANCY complications ,HEPATITIS C ,DATA analysis software ,CONFIDENCE intervals ,DISEASE risk factors ,DISEASE complications ,PREGNANCY - Abstract
Introduction: There are limited and conflicting data regarding the impact of hepatitis C in pregnancy on adverse birth outcomes. Methods: Using the Surveillance for Emerging Threats to Pregnant People and Infants Network (SET-NET), a large surveillance cohort, we describe birth outcomes among a cohort of people with HCV in pregnancy in total and by reported substance use. Results: Among 1418 infants, 89% were born to people with reported substance use during pregnancy. The proportion born preterm was 20%, 13% were small-for-gestational age and 34% of term infants required intensive care. Conclusions: Assessments of recent changes to recommendations for HCV screening in pregnancy should evaluate the impact on maternal access to care for both HCV treatment as well as comorbidities such as substance use disorder which may contribute to adverse birth outcomes. Significance: Incidence of hepatitis C in pregnancy is increasing. Prematurity, small-for-gestational age, and intensive care unit admission were common among this surveillance cohort of infants born to people with hepatitis C in pregnancy with high frequency of substance use. Assessments of recent changes to recommendations for HCV screening in pregnancy should evaluate the impact on maternal access to care for both HCV treatment as well as comorbidities such as substance use disorder which may contribute to adverse birth outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. A Preparedness Model for Mother–Baby Linked Longitudinal Surveillance for Emerging Threats
- Author
-
Woodworth, Kate R., Reynolds, Megan R., Burkel, Veronica, Gates, Cymone, Eckert, Valorie, McDermott, Catherine, Barton, Jerusha, Wilburn, Amanda, Halai, Umme-Aiman, Brown, Catherine M., Bocour, Angelica, Longcore, Nicole, Orkis, Lauren, Lopez, Camille Delgado, Sizemore, Lindsey, Ellis, Esther M., Schillie, Sarah, Gupta, Neil, Bowen, Virginia B., Torrone, Elizabeth, Ellington, Sascha R., Delaney, Augustina, Olson, Samantha M., Roth, Nicole M., Whitehill, Florence, Zambrano, Laura D., Meaney-Delman, Dana, Fehrenbach, S. Nicole, Honein, Margaret A., Tong, Van T., and Gilboa, Suzanne M.
- Published
- 2021
- Full Text
- View/download PDF
4. Using Public Health Surveillance Data to Determine Hepatitis C Virus Exposure Among Live-Born Infants in Tennessee, 2013-2017.
- Author
-
Wingate, Heather, Sizemore, Lindsey, Black, Jennifer, Heth, Zachary, Talley, Pamela, Patrick, Stephen W., and Wester, Carolyn
- Subjects
- *
HEPATITIS C transmission , *PUBLIC health surveillance , *MOTHERS , *PUBLIC health , *HEPATITIS viruses , *MOTHER-infant relationship , *LONGITUDINAL method - Abstract
Objective: Maternal hepatitis C virus (HCV) infection reported on birth certificates has been shown to underestimate HCV infection. We sought to determine the usefulness of HCV surveillance data for (1) quantifying the number of HCV-positive reproductive-aged women with a live birth, (2) comparing maternal HCV surveillance data with reported HCV infection status on birth certificates, and (3) delineating past versus current maternal infection to identify true perinatal exposures. Methods: We extracted data from January 1, 2013, through December 31, 2017, on birth certificate indication of HCV exposure from the Tennessee Birth Statistical File, and we ascertained indication of HCV exposure by using laboratory data from the Tennessee National Electronic Disease Surveillance System (NEDSS) Base System (NBS). We conducted a sensitivity analysis comparing birth certificate indication of HCV exposure with HCV laboratory data to determine whether true perinatal exposure had occurred. Results: During the study period, 6731 mothers with live births in Tennessee reported having HCV infection during pregnancy: 3295 (49.0%) had both laboratory and birth certificate indication of HCV infection, 2130 (31.6%) had indication of HCV infection on the laboratory report only, and 1306 (19.4%) had indication of HCV infection on the birth certificate only. Conclusions: Using data from a public health HCV surveillance system with birth certificate data may improve the identification of HCV-infected pregnant women and perinatally exposed infants. Surveillance systems that include complete reporting of all HCV RNA results can be used to distinguish past from present maternal HCV infection to focus limited public health resources on currently infected mothers and their exposed infants. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. SARS‐CoV‐2 infections among neonates born to pregnant people with SARS‐CoV‐2 infection: Maternal, pregnancy and birth characteristics.
- Author
-
Olsen, Emily O'Malley, Roth, Nicole M., Aveni, Kathryn, Santos, Pauline, Sizemore, Lindsey, Halai, Umme‐Aiman, Nestoridi, Eirini, Barton, Jerusha Elana, Mobley, Evan, Siebman, Samantha, Fussman, Chris, Mbotha, Deborah, Dzimira, Paula, Silcox, Kristin M., Khuwaja, Salma, Roscom, Danacamile, Lush, Mamie, Chicchelly, Sarah, Delgado‐López, Camille, and Schlosser, Levi
- Abstract
Background: Multiple reports have described neonatal SARS‐CoV‐2 infection, including likely in utero transmission and early postnatal infection, but published estimates of neonatal infection range by geography and design type. Objectives: To describe maternal, pregnancy and neonatal characteristics among neonates born to people with SARS‐CoV‐2 infection during pregnancy by neonatal SARS‐CoV‐2 testing results. Methods: Using aggregated data from the Surveillance for Emerging Threats to Mothers and Babies Network (SET‐NET) describing infections from 20 January 2020 to 31 December 2020, we identified neonates who were (1) born to people who were SARS‐CoV‐2 positive by RT‐PCR at any time during their pregnancy, and (2) tested for SARS‐CoV‐2 by RT‐PCR during the birth hospitalisation. Results: Among 28,771 neonates born to people with SARS‐CoV‐2 infection during pregnancy, 3816 (13%) underwent PCR testing and 138 neonates (3.6%) were PCR positive. Ninety‐four per cent of neonates testing positive were born to people with infection identified ≤14 days of delivery. Neonatal SARS‐CoV‐2 infection was more frequent among neonates born preterm (5.7%) compared to term (3.4%). Neonates testing positive were born to both symptomatic and asymptomatic pregnant people. Conclusions: Jurisdictions reported SARS‐CoV‐2 RT‐PCR results for only 13% of neonates known to be born to people with SARS‐CoV‐2 infection during pregnancy. These results provide evidence of neonatal infection identified through multi‐state systematic surveillance data collection and describe characteristics of neonates with SARS‐CoV‐2 infection. While perinatal SARS‐CoV‐2 infection was uncommon among tested neonates born to people with SARS‐CoV‐2 infection during pregnancy, nearly all cases of tested neonatal infection occurred in pregnant people infected around the time of delivery and was more frequent among neonates born preterm. These findings support the recommendation for neonatal SARS‐CoV‐2 RT‐PCR testing, especially for people with acute infection around the time of delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Pregnancy Status, Risk Factors, and Opportunities for Referral to Care Among Reproductive-Aged Women With Newly Reported Chronic Hepatitis C Virus Infection in Tennessee.
- Author
-
Oliver, Cassandra, Black, Jennifer, De Pont, Shannon, Sizemore, Lindsey, and Wester, Carolyn
- Subjects
INTRANASAL medication ,COUNSELING ,MATERNAL age ,MATERNAL health services ,PRISONERS ,MEDICAL referrals ,PUBLIC health surveillance ,SUBSTANCE abuse ,WOMEN'S health ,PATIENTS' attitudes ,CHRONIC hepatitis C ,DISEASE risk factors ,PREGNANCY - Abstract
Objectives: From 2006 through 2012, the number of acute hepatitis C virus (HCV) infections increased 364% among persons aged ≤30, including reproductive-aged women, in Central Appalachian states. Outreach to reproductive-aged women with newly diagnosed HCV infection affords a unique opportunity to provide counseling, further testing, and linkage to treatment. We modeled a centrally located statewide effort to reach this population and their health care providers to ascertain pregnancy status, HCV risk factors, and opportunities for linkage to additional services. Methods: Using the Tennessee Department of Health's surveillance database, we identified women aged 18-45 residing in Tennessee with newly reported chronic HCV infection from May through October 2017. We contacted health care providers and patients to request information on pregnancy status and HCV risk factors as well as to provide linkage to treatment services. Results: Of 1548 women included in this study, health care provider or patient contact information was available for 1316 (85.0%) women. Of the 1316 women, 806 (61.2%) women had a health care provider or patient response, of whom 242 (30.0%) were pregnant. Of 296 patients contacted, 194 (65.5%) reported intranasal drug use, 193 (65.2%) reported having been incarcerated for more than 24 hours, and 180 (60.8%) reported injection drug use. Ninety-eight (33.1%) patients were referred for confirmatory testing, and 174 (58.8%) were referred to treatment. Conclusion: A high proportion of reproductive-aged women with newly diagnosed HCV infection were pregnant. Surveillance-informed outreach to this population was feasible and provided opportunities for counseling and linkage to confirmatory testing and treatment. Future studies should evaluate whether a similar model would enhance testing and linkage to care of HCV-exposed infants. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Timing of Positive Hepatitis C Virus Test Results During and 1 Year Before Pregnancy.
- Author
-
Woodworth, Kate R., Newton, Suzanne M., Olsen, Emily O., Tannis, Ayzsa, Sizemore, Lindsey, Wingate, Heather, Orkis, Lauren, Reynolds, Bethany, Longcore, Nicole, Thomas, Nadia, Bocour, Angelica, Wills, Aprielle, Kim, Shin Y., Panagiotakopoulos, Lakshmi, Wester, Carolyn, Delman Meaney, Dana, Gilboa, Suzanne M., and Tong, Van T.
- Subjects
- *
HEPATITIS C virus , *HEPATITIS C , *PREGNANCY - Abstract
The incidence of hepatitis C virus (HCV) infection in reproductive-aged adults quadrupled during the past decade. Hepatitis C can progress to advanced liver disease and be transmitted perinatally. Highly effective curative hepatitis C treatment is available but is not recommended in pregnancy. Using the Surveillance for Emerging Threats to Mothers and Babies Network, we describe timing of positive RNA testing among pregnant people with HCV (HCV RNA detected during or within one year prior to pregnancy). Four US jurisdictions reported 1161 pregnancies during 2018-2021 among people with hepatitis C: 75.9% were multiparous; and 21.4% had their first peri-pregnancy HCV RNA detected prior to pregnancy, indicating potential missed treatment opportunities to improve maternal health and prevent perinatal transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.